• No results found

Pseudothrombocytopenia in a Preterm Neonate

N/A
N/A
Protected

Academic year: 2020

Share "Pseudothrombocytopenia in a Preterm Neonate"

Copied!
5
0
0

Loading.... (view fulltext now)

Full text

(1)

Pseudothrombocytopenia in a Preterm Neonate

Robert D. Christensen, MD*; Martha C. Sola, MD‡; Lisa M. Rimsza, MD§; Michael J. McMahan, MD

; and

Darlene A. Calhoun, DO*

ABSTRACT. Severe and prolonged thrombocytopenia is not uncommon among ill preterm infants. Pseudothrom-bocytopenia, which has the appearance of severe and prolonged thrombocytopenia, has not been described in this population. We observed a preterm neonate who had EDTA-independent pseudothrombocytopenia and con-clude that this condition should be considered when severe and prolonged thrombocytopenia occurs in a ne-onate in the absence of clinical signs of platelet-type hemorrhage.Pediatrics2004;114:273–275; thrombocytope-nia, pseudothrombocytopethrombocytope-nia, neonate, preterm.

P

seudothrombocytopenia is a rare condition in

which platelet counts are reported to be low,

often

10 000 per

L, yet no hemorrhagic

ten-dencies are present.

1–6

This condition involves

plate-let aggregation in vitro and is generally associated

with using the anticoagulant

ethylenediaminetet-raacetic acid (EDTA) in the blood-collection tube.

1–6

Shreiner and Bell first reported

pseudothrombocy-topenia in 1973,

1

and subsequently both

EDTA-pendant and -independent varieties have been

de-scribed.

2–6

Chiurazzi et al

7

reported a term neonate

with a transient, presumably transplacentally

ac-quired variety of EDTA-dependant

pseudothrombo-cytopenia, but we know of no cases among preterm

infants. In fact, we are aware of no cases in neonates

other than the Chiurazzi et al case.

We recently observed a preterm neonate who had

severe and prolonged thrombocytopenia, in whom

many platelet counts were

10 000 per

L, and

several were 0 per

L; however, no clinical bleeding

problems were seen, and the bleeding time was

nor-mal. Platelet counts in citrate-containing and in

EDTA-containing tubes were identical, and

numer-ous platelet clumps were observed on the blood film.

These results, taken together with the clinical history

and lack of thrombocytopenia in the mother, suggest

that our patient had EDTA-independent

pseudo-thrombocytopenia and thus fundamentally differs

from the Chiurazzi et al

7

case.

CASE REPORTS

The patient was delivered at 26 weeks’ gestation to a healthy 22-year-old primigravida by caesarian section at Arnold Palmer Hospital for Women and Children for suspected abruption and preterm labor. Apgar scores were 2 and 7 at 1 and 5 minutes, respectively, and birth weight was 886 g. The male infant received exogenous surfactant in the delivery room. His complete blood count on admission to the neonatal intensive care unit revealed a platelet count of 8000 per␮L. The hematocrit was 41.4%, and the leukocyte count was 5800 per␮L, with 39% segmented neutro-phils and 13% bands. No dysmorphic features were observed, and no petechiae, purpura, or bleeding were noted. Because of the low platelet count, a platelet transfusion, consisting of 15 mL/kg non-packed, single-donor platelets, was given.

Over the following week, platelet counts ranged from 17 000 to 47 000 per␮L, and 4 additional platelet transfusions were given. However, no petechiae, purpura, or clinical bleeding were seen. The prothrombin time was normal at 13.7 seconds, the fibrinogen was normal at 226 mg/L, and a heparin platelet antibody study was negative. Cultures of urine for cytomegalovirus and blood cultures for bacteria were negative. IgM titers for cytomegalovi-rus, rubella, and toxoplasmosis were negative. The mother’s and infant’s serum were negative for antiplatelet antibodies. The mother’s platelet count was normal, and she had no history of thrombocytopenia or abnormal bleeding.

Because of the lack of any bleeding manifestation, it was de-cided to administer platelet transfusions only if the platelet count was⬍10 000 per␮L rather than the usual “trigger” level in this neonatal center of⬍25 000 per␮L.8On 2 occasions the platelet

count was reported as 0 per␮L. During the second week of life, the pathologist noted clumping of the platelets on the blood film. At 13 weeks of age, the patient underwent surgical repair of bilateral inguinal hernias. He received a platelet transfusion the day before surgery, which resulted in a platelet count of 43 000 per ␮L on the day of surgery and 14 000 per␮L the day after surgery. Platelets were available for transfusion during the surgery but were not given because no abnormal bleeding was observed.

A Surgicutt newborn bleeding time test, done when the platelet count was 2000 per␮L, was normal for age and hematocrit (24%) at 4 minutes, 15 seconds.9Electronic platelet counts were done on

blood simultaneously drawn into an EDTA-containing tube and into a citrate-containing tube. Both were 2000 per␮L. A blood film made directly from an automated lance wound of the heel dem-onstrated few scattered platelets of normal size and morphology but many platelet clumps, particularly at the edge of the blood film (Fig 1). The nonclumped platelets appeared normal in size and shape.

After a diagnosis of pseudothrombocytopenia was made, the patient had no additional platelet counts or platelet transfusions. At 17 weeks, he was discharged from the hospital on 0.1 L of O2

per min. Two cranial ultrasound studies were done during the hospitalization; one at 1 week and one at 6 weeks of life, and both were normal with no evidence of hemorrhage. Before this was recognized to be pseudothrombocytopenia, he had 90 platelet counts and 29 platelet transfusions. Three months after discharge, he was still receiving 0.1 L of O2per min. He had 2 brief

hospi-talizations for upper respiratory infections. His growth has been normal, and he has had no petechiae, purpura, epistaxis, or any hemorrhagic or thrombotic problems. He has no additional plate-let counts.

From the *Division of Neonatology, Department of Pediatrics, University of South Florida College of Medicine and All Children’s Hospital, St Peters-burg, Florida; ‡Division of Neonatology, Department of Pediatrics, Univer-sity of Florida College of Medicine, Gainesville, Florida;㛳Division of Neo-natology, Arnold Palmer Hospital for Women and Children, Orlando, Florida; and §Division of Hematopathology, Department of Pathology, University of Arizona College of Medicine, Tucson, Arizona.

Received for publication Jul 21, 2003; accepted Nov 13, 2003.

Address correspondence to Robert D. Christensen, MD, All Children’s Hospital, 801 Sixth St S, Box 9360, St Petersburg, FL 33701. E-mail: [email protected]

PEDIATRICS (ISSN 0031 4005). Copyright © 2004 by the American Acad-emy of Pediatrics.

PEDIATRICS Vol. 114 No. 1 July 2004 273

at Viet Nam:AAP Sponsored on August 29, 2020

www.aappublications.org/news

(2)

DISCUSSION

Severe thrombocytopenia in a preterm neonate

generally triggers a platelet transfusion.

8,10,11

How-ever, if it were known that the case was actually a

pseudothrombocytopenia, and therefore the risk for

serious bleeding was not increased, platelet

transfu-sions would not be given.

1–6

We observed a preterm

neonate who had severe and prolonged

thrombocy-topenia but had no clinical bleeding problems. Even

when the platelet count was recorded as 0 per

L,

no petechiae, purpura, or other hemorrhagic

prob-lems were seen. Moreover, the patient had no

intra-ventricular hemorrhage, although he was born at 26

weeks’ gestation with hyaline membrane disease and

a platelet count of 8000 per

L. No abnormal bleeding

was observed after bilateral herniorrhaphy with a

platelet count of 14 000 per

L. This lack of hemorrhage

is concordant with the normal bleeding time but

dis-cordant with the repeatedly very low platelet counts.

The clinical history and multiple platelet clumps

seen on the blood film indicate

pseudothrombocyto-penia. The appearance of platelet clumps when

blood was drawn into citrate-containing tubes, or

into EDTA or into no anticoagulant, excludes the

usual type of EDTA-dependent

pseudothrombo-cytopenia and suggests the diagnosis of

non–EDTA-dependent pseudothrombocytopenia. It is thought

that EDTA-dependent pseudothrombocytopenia is

mediated by antibody.

1–6

However, this mechanism

is unlikely in our case, which is more likely due to a

specific platelet abnormality. Our case differs from

the transplacentally acquired case described by

Chiurazzi et al

7

in that our patient’s mother was not

affected, he did not remit in 1 month, and his

plate-lets clumped in citrate as well as in EDTA.

To our knowledge, no previous cases of

pseudo-thrombocytopenia have been reported among

pre-term neonates, and thus this is certainly a rare

con-dition. However, the present case is instructive,

affirming the adage that physicians should treat the

patient and not the laboratory value. Furthermore,

the case illustrates that pseudothrombocytopenia can

indeed occur in the neonatal intensive care unit and

should be considered when severe and prolonged

thrombocytopenia occurs in the absence of clinical

signs of platelet-type hemorrhage.

ACKNOWLEDGMENTS

This work was supported by National Institutes of Health grants HL-61798 and HL-69990.

We thank Dr John Lazarchick (Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Fig 1. A compilation of several photomicrographs that were taken from a single blood film made without anticoagulant and stained with Wright/Giemsa (A, D, and E: original magnification⫻400; B and C: original magnification⫻1000).

(3)

Charleston) for helpful discussions of the case and Aaron Barley-corn and Dr Wenge Lu for technical assistance.

REFERENCES

1. Shreiner DP, Bell WR. Pseudothrombocytopenia: manifestation of a new type of platelet agglutinin.Blood.1973;42:541–549

2. Mant MJ, Doery JC, Gauldie J, Sims H. Pseudothrombocytopenia due to platelet aggregation and degranulation in blood collected in EDTA. Scand J Haematol.1975;15:161–170

3. Onder O, Weinstein W, Hoyer LW. Pseudothrombocytopenia caused by platelet agglutinins that are reactive in blood anticoagulated with che-lating agents.Blood.1980;56:177–182

4. Bartels PC, Schoori M, Llombarts AJ. Screening for abnormalities in platelet distribution histograms in pseudothrombocytopenia. Scand J Clin Lab Invest.1997;57:629 – 636

5. Berkman N, Michaeli Y, Or R, Eldon A. EDTA-dependent pseudo-thrombocytopenia: a clinical study of 18 patients and review of the literature.Am J Hematol.1991;36:195–201

6. Bizzaro N. EDTA-dependent pseudothrombocytopenia: a clinical and epidemiological study of 112 cases, with 10-year follow-up.Am J He-matol.1995;50:103–109

7. Chiurazzi F, Villa MR, Rotoli B. Transplacental transmission of EDTA-dependent pseudothrombocytopenia.Haematologica.1999;84:664 8. Calhoun DA, Christensen RD, Edstrom CS, et al. Consistent approaches

to procedures and practices in neonatal hematology. Clin Perinatol. 2000;27:733–754

9. Sola MC, Edwards TJ, Del Vecchio A, Suttner D, Hutson AD, Chris-tensen RD. A low hematocrit prolongs the bleeding time of very low birth-weight infants in the first week of life. J Perinatol.2001;201: 368 –371

10. Sola MC, Del Vecchio A, Rimsza LM. Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit.Clin Perinatol. 2000;27:655– 680

11. Del Vecchio A, Sola MC, Garcia MG, et al. Platelet transfusions in the neonatal intensive care unit: factors predicting patients who will require multiple transfusions.Transfusion.2001;41:803– 808

EXPERIENCE AND REASON 275

at Viet Nam:AAP Sponsored on August 29, 2020

www.aappublications.org/news

(4)

DOI: 10.1542/peds.114.1.273

2004;114;273

Pediatrics

Darlene A. Calhoun

Robert D. Christensen, Martha C. Sola, Lisa M. Rimsza, Michael J. McMahan and

Pseudothrombocytopenia in a Preterm Neonate

Services

Updated Information &

http://pediatrics.aappublications.org/content/114/1/273

including high resolution figures, can be found at:

References

http://pediatrics.aappublications.org/content/114/1/273#BIBL

This article cites 11 articles, 3 of which you can access for free at:

Subspecialty Collections

http://www.aappublications.org/cgi/collection/blood_disorders_sub

Blood Disorders

sub

http://www.aappublications.org/cgi/collection/hematology:oncology_

Hematology/Oncology

http://www.aappublications.org/cgi/collection/neonatology_sub

Neonatology

sub

http://www.aappublications.org/cgi/collection/fetus:newborn_infant_

Fetus/Newborn Infant

following collection(s):

This article, along with others on similar topics, appears in the

Permissions & Licensing

http://www.aappublications.org/site/misc/Permissions.xhtml

in its entirety can be found online at:

Information about reproducing this article in parts (figures, tables) or

Reprints

http://www.aappublications.org/site/misc/reprints.xhtml

Information about ordering reprints can be found online:

at Viet Nam:AAP Sponsored on August 29, 2020

www.aappublications.org/news

(5)

DOI: 10.1542/peds.114.1.273

2004;114;273

Pediatrics

Darlene A. Calhoun

Robert D. Christensen, Martha C. Sola, Lisa M. Rimsza, Michael J. McMahan and

Pseudothrombocytopenia in a Preterm Neonate

http://pediatrics.aappublications.org/content/114/1/273

located on the World Wide Web at:

The online version of this article, along with updated information and services, is

by the American Academy of Pediatrics. All rights reserved. Print ISSN: 1073-0397.

the American Academy of Pediatrics, 345 Park Avenue, Itasca, Illinois, 60143. Copyright © 2004

has been published continuously since 1948. Pediatrics is owned, published, and trademarked by

Pediatrics is the official journal of the American Academy of Pediatrics. A monthly publication, it

at Viet Nam:AAP Sponsored on August 29, 2020

www.aappublications.org/news

Figure

Fig 1. A compilation of several photomicrographs that were taken from a single blood film made without anticoagulant and stained withWright/Giemsa (A, D, and E: original magnification �400; B and C: original magnification �1000).

References

Related documents

Whereas early screening approaches asked patients and families to report the number of hours of “ screen time, ” the 2016 American Academy of Pediatrics (AAP) policy statement on

India in the time of

Antibiotics such as penicillin work by disrupting cell wall synthesis thereby causing the cells to lose integrity and lyse during replication. This occurs relatively rapidly, about

The Bath Ankylosing Spondylitis Disease Activity Index, Bath Ankylosing Spondylitis Functional Index, Bath Ankylosing Spondylitis Metrology Index, pain visual analog scale,

This method involves depletion of abundant serum proteins, two- dimensional liquid chromatography, protein macroarrays probed with RA and control sera to identify fractions

This study relates to a THET Health links partner- ship established between a UK virtual palliative care faculty (established specifically for this project) and the education team

Regi on of State Central / Lakes Connecti cut Val l ey Manchester Area Mass Border North Country Seacoast.

The higher hardness levels observed in state 2 films were due to higher (near 50 at. %) concentrations of carbon in the films.. 8.5 shows the Knoop hardness of SCC for films